Reunion Neuroscience
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Reunion Neuroscience generated cash of -$27,917,058, which is more than the previous year. Cash used in financing activities reached the amount of -$810,925 last year. Net change in cash is therefore -$36,779,801.
Cash Flow
| 2020 | -1.93M | -940.90K | 12.61M |
|---|---|---|---|
| 2021 | -16.41M | -75.07M | 121.28M |
| 2022 | -44.26M | 68.92M | -265.75K |
| 2023 | -27.91M | -7.60M | -810.92K |
REUN Cash Flow Statement (2020 – 2023)
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
Cash at beginning of period | 64.49M | 39.85M | 9.69M | 0 |
Operating activities | ||||
Net income | -48.49M | -54.69M | -23.11M | -2.62M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||
Depreciation and amortization | 3.22M | 3.60M | 1.39M | 146.32K |
Stock-based compensation expense | 2.83M | 7.16M | 3.04M | 330.70K |
| Deferred income tax benefit | 2.83M | 7.16M | 3.04M | 330.70K |
| Changes in operating assets and liabilities: | ||||
Accounts receivable, net | 478.28K | -449.42K | -610.64K | -209.45K |
Inventories | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -27.91M | -44.26M | -16.41M | -1.93M |
Investing activities | ||||
Purchases Of Investments | -7.78M | 0 | -72.54M | 0 |
Investments In Property Plant And Equipment | -246.10K | -3.62M | -2.52M | -940.90K |
Acquisitions Net | -9.80M | 0 | 0 | 0 |
Cash generated by investing activities | -7.60M | 68.92M | -75.07M | -940.90K |
Financing activities | ||||
Common Stock Issued | 67.66K | 0 | 124.79M | 12.73M |
Payments for dividends | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -806.65K | -108.90K |
Cash used in financing activities | -810.92K | -265.75K | 121.28M | 12.61M |
Net Change In Cash | -36.77M | 24.64M | 30.16M | 9.69M |
Cash at end of period | 27.71M | 64.49M | 39.85M | 9.69M |